Trials / Active Not Recruiting
Active Not RecruitingNCT06397885
Prospective on Market Patient-reported Outcomes for Milli
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Materna Medical · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness of the Milli device in achieving vaginal intercourse
Detailed description
The Milli Vaginal Dilator is a patient-controlled vaginal dilator that provides therapy through distention of the vaginal tissue under electromechanical expansion. This study is intended to provide data in support of the Milli Vaginal Dilator as a commercially available, over-the-counter medical device. The Milli has been granted marketing authorization by the FDA under premarket notification K220035 for the following Indications for Use statement: The Milli Vaginal Dilator is a tool indicated for controlled dilation of the vagina. It can be used for dilation for an examination (by your doctor), in preparation for a surgical procedure, or to help relieve the symptoms of vaginismus (condition that involves tightening of the vaginal muscles) and related painful sex. .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Milli Vaginal Dilator | Patient-controlled vaginal dilator that provides therapy through distention of the vaginal tissue under electromechanical expansion |
Timeline
- Start date
- 2024-05-12
- Primary completion
- 2025-11-30
- Completion
- 2025-12-30
- First posted
- 2024-05-03
- Last updated
- 2024-11-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06397885. Inclusion in this directory is not an endorsement.